Improved antibacterial function of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus

被引:38
作者
Ghaderkhani, Jalal [1 ]
Yousefimashouf, Rasoul [1 ]
Arabestani, Mohammadreza [1 ]
Roshanaei, Ghodratollah [2 ]
Asl, Sara Soleimani [3 ]
Abbasalipourkabir, Roghayeh [4 ]
机构
[1] Hamadan Univ Med Sci, Dept Microbiol, Hamadan, Iran
[2] Hamadan Univ Med Sci, Modeling Noncommunicable Dis Res Ctr, Sch Publ Hlth, Dept Biostat & Epidemiol, Hamadan, Iran
[3] Hamadan Univ Med Sci, Endometrium & Endometriosis Res Ctr, Hamadan, Iran
[4] Hamadan Univ Med Sci, Dept Biochem, Hamadan, Iran
关键词
Solid lipid nanoparticles; rifampicin; antibacterial activity; Brucella abortus; IN-VITRO; DELIVERY-SYSTEMS; STEARIC-ACID; FORMULATION; CRYSTALLINITY; ENCAPSULATION; STREPTOMYCIN; MACROPHAGES; MELITENSIS; STABILITY;
D O I
10.1080/21691401.2019.1593858
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The objective of this study was to assess the antibacterial activity of Rifampicin-loaded solid lipid nanoparticles on Brucella abortus 544. Rifampicin-loaded solid lipid nanoparticles were prepared by a modified microemulsion/sonication method and characterized. The results showed the average size about 319.7 nm, PI about 0.20 and zeta potential about 18.4 mv, encapsulation efficacy and drug-loading were equal to 95.78 and 34.2%, respectively, with a spherical shape. Drug release lasted for 5 days. The antibacterial activity was statistically significant with rho < .05 in bacterial and cell culture media compared to free Rifampicin. It can be concluded that solid lipid nanoparticles can be considered as a promising delivery system for improving the antibacterial activity of Rifampicin against Brucella abortus.
引用
收藏
页码:1181 / 1193
页数:13
相关论文
共 50 条
  • [1] Aboutaleb E, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-33
  • [2] A preliminary investigation to group disparate batches of licit and illicit diazepam tablets using differential scanning calorimetry
    Bibi, S.
    Bremner, D. H.
    Macdougall-Heasman, M.
    Reid, R.
    Simpson, K.
    Tough, A.
    Waddell, S.
    Stewart, I. J.
    Matthews, K. H.
    [J]. ANALYTICAL METHODS, 2015, 7 (20) : 8597 - 8604
  • [3] Bodaghabadi Narges, 2018, Iranian Biomedical Journal, V22, P275, DOI 10.22034/ibj.22.4.275
  • [4] Delivery systems to increase the selectivity of antibiotics in phagocytic cells
    Briones, Elsa
    Colino, Clara Isabel
    Lanao, Jose M.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2008, 125 (03) : 210 - 227
  • [5] In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel
    Chen, DB
    Yang, TZ
    Lu, WL
    Zhang, Q
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (11) : 1444 - 1447
  • [6] Pathogenesis and Immunobiology of Brucellosis Review of Brucella-Host Interactions
    de Figueiredo, Paul
    Ficht, Thomas A.
    Rice-Ficht, Allison
    Rossetti, Carlos A.
    Adams, L. Garry
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (06) : 1505 - 1517
  • [7] Development and evaluation of taste-masked dry suspension of cefuroxime axetil for enhancement of oral bioavailability
    Du, Yuqian
    Zhai, Yinglei
    Zhang, Juhong
    Wu, Chunnuan
    Luo, Cong
    Sun, Jin
    He, Zhonggui
    [J]. ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 8 (05) : 287 - 294
  • [8] Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles
    Ebrahimi, Hossein Ali
    Javadzadeh, Yousef
    Hamidi, Mehrdad
    Jalali, Mohammad Barzegar
    [J]. DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 23
  • [9] Ekambaram P, 2011, J YOUNG PHARM, V3, P216, DOI [10.4103/0975-1483.83765, 10.410310975-1483.83765]
  • [10] Farazi A. A., 2014, Arak Medical University Journal, V17, P47